{
  "main_header": {
    "sid": 1002605,
    "name": "Fredun Pharma",
    "stock_name": "Fredun Pharma",
    "full_name": "Fredun Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/fredun-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,553.15",
    "chg": 18.9,
    "chgp": "1.23%",
    "dir": 1,
    "prev_price": "1,534.25",
    "mcapval": "2,568.61 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539730,
    "symbol": "FREDUN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE194R01017",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "53.94 k",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/fredun-pharma-1002605-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 15,
    "sid": "1002605",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/fredun-pharmaceuticals-1002605"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment",
      "datetime": "05-Oct-2026",
      "details": "Revised Allotment of Rs. 182400 Equity Shares.",
      "source": "BSE"
    },
    {
      "caption": "Revised Outcome Of Board Meeting Dated 03Rd October 2026.",
      "datetime": "05-Oct-2026",
      "details": "Revised Outcome of Board Meeting Dated 03rd October 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Allotment Of 182400 Equity Shares To Non-Promoter Allottees Pursuant To Conversion Of 60800 Warrants Into Equity Shares Consequent To The 1:2 Bonus Issue.",
      "datetime": "03-Oct-2026",
      "details": "Allotment of 182400 Equity Shares to Non-Promoter Allottees pursuant to conversion of 60800 Warrants into Equity Shares consequent to the 1:2 Bonus Issue.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Fredun Pharmaceuticals Ltd has declared <strong>7%</strong> dividend, ex-date: 23 Jun 26",
          "dt": "2026-06-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Fredun Pharmaceuticals Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 16 Jul 26",
          "dt": "2026-07-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News